Azelaic Acid 99.0+% Micro 500G Drug Recalled for cGMP Deviations
API Solutions Inc. is voluntarily recalling Azelaic Acid 99.0+% Micro 500 Grams (Lot #AZA181105, Exp 11/09/2021) distributed in five states due to current Good Manufacturing Practice (cGMP) deviations identified during manufacturing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving cGMP deviations. The source text does not report any illnesses, injuries, or adverse events. The hazard is a manufacturing process deficiency rather than a confirmed contamination or defect, making this a moderate-severity, precautionary recall.
Plain-English summary
API Solutions Inc. is voluntarily recalling one batch of Azelaic Acid 99.0+% Micro 500 Grams. The product was manufactured by Yicheng Chemicals Corp. in China and distributed by Syntec Pharma Corp. in New York through API Solutions Inc. in Daphne, Alabama.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations. cGMP violations can affect the quality, purity, and potency of pharmaceutical products.
The affected lot is Lot #AZA181105 with an expiration date of 11/09/2021. Distribution was limited to Alabama, Arizona, Colorado, Florida, and Virginia.
Consumers and healthcare providers who have this product should stop using it and contact API Solutions Inc. for instructions on return or disposal. The FDA classified this as a Class II recall. The recall was voluntarily initiated by the firm on July 15, 2021, and was terminated on February 8, 2022.
The recalled product
- Product
- Azelaic Acid 99.0+% Micro 500 Grams, Distributed By: A.P.I. Solutions Daphne Alabama Manufactured by: Yicheng Chemicals Corp. China Distributed by: Syntec Pharma Corp New York
- Manufacturer
- API Solutions Inc.
- Hazard
- manufacturing-defect
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AZA181105
- Exp 11/09/2021
Distribution
Distributed in 5 states:
- AL
- AZ
- CO
- FL
- VA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27